Objective: To determine the role of complete blood count and coagulation function factors as in ammatory markers in intrahepatic cholestasis of pregnancy (ICP). Study Design: Descriptive, analytical study. Place and Duration of Study: Department of Obstetrics and Gynecology, Bursa Yüksek 0htisas Training and Research Hospital, Bursa, Turkey, between January 2018 and 2021. Methodology: This study was conducted with a total of 200 pregnant women, 80 with ICP and 120 control healthy pregnant women. The diagnosis of ICP was made based on elevated liver enzymes and bile acids (e10 ¼mol/L) and pruritis. oRutine complete blood count parameters and coagulation function tests werecompared between both groups. ROC analyses were used to analyse the predictive value of brinogen levels in ICP. Spearman s rank correlation analysis assessed the correlation between fasting bile acid value and complete blood count and coagulation parameters. Results: Neutrophil-lymphocyte ratio (NLR), Platelet count, and Platecrit levels were signi cantly higher in the ICP group, and red blood cell distribution width (RDW) was lower than in the healthy group (p <0.05). The median plasma brinogen value was 571 mg/dl which was signi cantly higher in pregnant women with cholestasis (p <0.001). The prothrombin time and international normalized ratio (INR) values were also signi cantly di erent in each group (p <0.001 and 0.013, respectively). In addition, platelet distribution width (PDW), plasma brinogen, and prothrombin time (PT) showed signi cant association with the bile acid values (p values=0.007, 0.03, and 0.04 respectively). Each 1-unit elevation of the brinogen increased the risk of cholestasis by 1.02 times. There was a positive correlation of 0.24-fold between the plasma brinogen value and acids. Conclusion: The plasma brinogen value was the highest predictor of cholestasis diagnosis by analyzing blood parameters. Elevated brinogen levels correlated with bile acid levels, can potentially detect ICP.